Please find below the PDFs and video recordings from the conference presentations. These materials are posted with speakers’ consent. If the session you are looking for is not listed below, it means that the speaker did not allow for his/her presentation to be available online. We will continue adding presentations, so please check back for updates.
We are working on getting presentations from this past week up online!
Pre-Conference: Wednesday, March 1, 2017
Evolutionary Origins of Stigma and the Intersectionality of FASD
Peter W. Choate
The Neuroscience of Addiction: Is it a Choice?
George F. Koob
The Science of Stigma
Patrick Corrigan
How Social Media Anonymity and the Words We Use Sustain Stigma
Kathleen T. Mitchell
Panel Presentation: Living with Stigma – the Not So Pretty
Bernadette Fuhrmann, Niall Schofield, Myles Himmelreich
Pre-Conference Wrap Up Presentation Slides
Main Conference: Thursday, March 2, 2017
The Prevalence and Epidemiologic Characteristics of FASD in General Populations of the United States: Final CoFASP Results
Introduction by: Kenneth R. Warren | Plenary: Philip A. May, Christina D. Chambers
A1. 4 Oral papers
A2. 4 Oral papers
A2a – Ethanol-Induced Neuroinflammation in the Developing Hippocampus: Mast Cells and Microglia
Derick Lindquist
A2c – Methyl Donors and Anti-oxidants Reduce Congenital Heart and Other Defects Induced by Prenatal Alcohol Exposure
Michiko Watanabe
A2d – Rodent Models for Medication Development and Their Application to Treat Fetal Alcohol Exposure
Susan Barron
A3. 4 Oral Papers
A3b – Initial Steps in Establishing Reservation and Urban Community Support/Resources for AIAN Families Dealing with FASD
Annika Montag
A3c – Soft Neurological Signs and Prenatal Alcohol Exposure: a Population-based Study in Remote Australia
Barbara Lucas
A5. The Essential Role of Growth Deficiency in the Diagnosis of FASD
Susan Astley
B1. 4 Oral Papers
B1c – c The Nurse’s Role in Alcohol Screening and Brief Intervention (aSBI) as an FASD Prevention Strategy
Marilyn Pierce-Bulger
B2. 4 Oral Papers
B2b – Perinatal Maternal Alcohol Consumption and Methylation of the Dopamine Receptor DRD4 in the Offspring: the Triple B Study
Elizabeth Elliott
B2c – Genetic Susceptibility to FASD
Johann Eberhart
Plenary: A Global Picture of FASD: Alcohol, Incidence and Practicality
Vladimir Poznyak, Svetlana Popova, Larry Burd
Main Conference: Friday, March 3, 2017
The Collaborative Initiative on FASD: New Findings on Screening
Edward Riley
Brain Imaging and Connectivity, an Adjunct to Screening
Jeffrey Wozniak
The Use of Functional Near-Infrared Spectroscopy to Differentiate Alcohol-Related Neurodevelopmental Imparment During a Task Eliciting Emotional Frustration
Julie Kable
miRNA Biomarkers for Fetal Alcohol Exposure in Pregnant Women
Rajesh Miranda
Immune Biomarkers of Prenatal Alcohol Exposure: How These Relate to Screening
Joanne Weinberg
Alterations in Genes Impacting Circadian Rhythms and Stress Axis: Possible Markers for FASD
Dipak K. Sarkar
C1. 4 Oral Papers
C1a – Choline as a Neurodevelopmental Intervention in Young Children with FASD
Jeffrey Wozniak
C2. 4 Oral Papers
C3. 4 Oral Papers
C3d – Sleep and Melatonin Secretion Abnormalities in Children and Adolescents with Fetal Alcohol Spectrum Disorders
Louise Scott
C6. Reunion Island – A Comprehensive and Collaborative Model of Prevention and Research on FASD
Denis Lamlin, Joelle Balanche, Patrick Chauvin
D2. 4 Oral Papers
D2a – FASD in Adopted Children in Israel
Emily R Fisher
D2c – Changes in Research, Prevention and Interventions in the Area of FASD in Poland in the Recent Decades
Katarzyna Okulicz-Kozaryn
D3. 4 Oral Papers
D3a – The Prenatal Alcohol History – It Is Hard to Get and it Matters How We Define It
Susan Petryk
D4. Including Sensory Dysregulation (SD) in Every Diagnosis of FASD
Louise Scott, Liv Elliott, Lisa Wahbe
D8a. Optimizing a Clinical Language Measure for Use in Identifying Significant Neurodevelopmental Impairment in Diagnosis of FASD
John C. Thorne
D8b. Characterizing Central Auditory Processing and Sound-in-Noise Listening Deficits in Individuals with FASD
Susan McLaughlin, John C. Thorne, Adrian KC Lee
D10. University of Washington FASDPN Database Released Worldwide
Susan Astley
Main Conference: Saturday, March 4, 2017
Cutting Edge Biomarkers – Are We Getting There?
Elodie Portales-Casamar
Prevalence Rates of Prenatal Alcohol Exposure from Detection of Phosphatidylenthanol (PEth) in Dried Blood Spots
Aileen Baldwin
Serum Aminopeptidase Activity as a Potential Persistent marker of Prenatal Alcohol Exposure
Paul Gard
E2. 4 Oral Papers
E2a – Stress Reduction Coaching for Caregivers at the FASD Specialist Centre Leipzig
Heike Hoff-Emden
E2b – Quality of Maternal Interaction Ameliorates the Effects of Prenatal Alcohol and/or Opioid Exposures on Infant’s Emotional Regulation at 6 Months of Age
Ludmila Bakhireva
E2d – Behaviour in Children with FASD: the Lililwan Study
Elizabeth Elliott
E3. 4 Oral Papers
E3a – Potential Pitfalls and Challenges to Providing Psychological Services for Young People with FASD Within the Western Australian Juvenile Justice System
Annette Paul, Carmela Pestell
E5 – Comparison of the FASD 4-Digit Code and Hoyme et al 2016 FASD Diagnostic Guidelines when Applied to the Records of 1,814 Individuals
Susan Astley, Julia Bledsoe, Julian Davies, John C. Thorne
E6. Prenatal Alcohol Exposure and Social Behavior Function: Challenges Associated with Navigating the Social World with FASD
Katina Kully-Martens, Sabrina Agnihotri, Parker J. Holman
E8 – (Sterling Clarren Award Presentation) Northern Ontario Health Care Students’ Knowledge and Self-Efficacy Regarding Fetal Alcohol Spectrum Disorder
Kelly D. Coons
Long Term Chronic Disease Outcomes Following Prenatal Alcohol Exposure
Karen Moritz
Plenary Panel: The Lay of the Land: Final Results of a Health Survey of 500+ Adults with Diagnosed FASD
Myles Himmelreich, CJ Lutke, Emily Travis